Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive

ClinicalTrials.gov ID: NCT00196326

Public ClinicalTrials.gov record NCT00196326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 4:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose, Combination Oral Contraceptive, Which Utilizes Ethinyl Estradiol During the Seven Day Interval Between Each 84-day Cycle

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an open-label, single treatment study. All subjects will receive one year of oral contraceptive therapy with DR-1011. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary.

Study identification

NCT ID
NCT00196326
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duramed Research
Industry
Enrollment
2,235 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2005
Primary completion
May 31, 2007
Completion
May 31, 2007
Last update posted
Nov 15, 2016

2005 – 2007

United States locations

U.S. sites
55
U.S. states
23
U.S. cities
49
Facility City State ZIP Site status
Duramed Investigational Site Huntsville Alabama 35801
Duramed Investigational Site Phoenix Arizona 85013
Duramed Investigational Site Phoenix Arizona 85031
Duramed Investigational Site Phoenix Arizona 85032
Duramed Investigational Site Tucson Arizona 85712
Duramed Investigational Site San Diego California 92103
Duramed Investigational Site San Diego California 92108
Duramed Investigational Site Colorado Springs Colorado 80907
Duramed Investigational Site Colorado Springs Colorado 80909
Duramed Investigational Site Denver Colorado 80202
Duramed Investigational Site New London Connecticut 06320
Duramed Investigational Site Coral Cables Florida 33134
Duramed Investigational Site Hollywood Florida 33024
Duramed Investigational Site Jacksonville Florida 32216
Duramed Investigational Site Leesburg Florida 34748
Duramed Investigational Site Miami Florida 33143
Duramed Investigational Site Palm Springs Florida 33437
Duramed Investigational Site Sarasota Florida 34239
Duramed Investigational Site Tampa Florida 33607
Duramed Investigational Site Decatur Georgia 30034
Duramed Investigational Site Douglasville Georgia 30134
Duramed Investigational Site Boise Idaho 83704
Duramed Investigational Site Chicago Illinois 60611
Duramed Investigational Site Shawnee Mission Kansas 66216
Duramed Investigational Site Topeka Kansas 66614
Duramed Investigational Site Louisville Kentucky 40291
Duramed Investigational Site Kansas City Missouri 64106
Duramed Investigational Site St Louis Missouri 63110
Duramed Investigational Site Lawrenceville New Jersey 08648
Duramed Investigational Site Moorestown New Jersey 08057
Duramed Investigational Site New Brunswick New Jersey 08901
Duramed Investigational Site Rochester New York 14609
Duramed Investigational Site Charlotte North Carolina 28222
Duramed Investigational Site Wilmington North Carolina 28412
Duramed Investigational Site Winston-Salem North Carolina 27103
Duramed Investigational Site Columbus Ohio 43205
Duramed Investigational Site Columbus Ohio 43213
Duramed Investigational Site Oklahoma City Oklahoma 73112
Duramed Investigational Site Medford Oregon 97504
Duramed Investigational Site Philadelphia Pennsylvania 19114
Duramed Investigational Site Pittsburgh Pennsylvania 15206
Duramed Investigational Site Pittsburgh Pennsylvania 15213
Duramed Investigational Site Willow Grove Pennsylvania 19090
Duramed Investigational Site Dallas Texas 75390
Duramed Investigational Site Houston Texas 77030
Duramed Investigational Site San Antonio Texas 78229
Duramed Investigational Site Waco Texas 76712
Duramed Investigational Site Salt Lake City Utah 84124
Duramed Investigational Site Newport News Virginia 23602
Duramed Investigational Site Norfolk Virginia 23507
Duramed Investigational Site Richmond Virginia 23226
Duramed Investigational Site Lakewood Washington 98499
Duramed Investigational Site Seattle Washington 98105
Duramed Investigational Site Spokane Washington 99207
Duramed Investigational Site Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00196326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 15, 2016 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00196326 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →